MyBlueDotsMirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) MyBlueDots2 weeks ago01 mins FOSTER CITY, Calif.–(BUSINESS WIRE)–Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Go to Source Author: Post navigation Previous: Mettler-Toledo International Inc. to Host Fourth Quarter 2024 Earnings Conference CallNext: Clinical trial highlights promising new treatment for intestinal worms
People who are autistic and transgender/gender diverse have poorer health and health care, study finds MyBlueDots18 hours ago 0
Digital therapeutics: Exploring the road to commercialization across international markets MyBlueDots22 hours ago 0